People are being diagnosed with chlamydia and gonorrhea at a higher rate than ever before, according to the Centers for Disease Control and Prevention (CDC).
The U.S. Preventive Services Task Force (USPSTF) recently reviewed the latest evidence on screening for chlamydia and gonorrhea and ultimately issued an update to their 2014 recommendation.
The new recommendation, published in JAMA, deems screening for chlamydia and gonorrhea "critical because these STIs often do not cause symptoms, which makes them harder to detect," according to USPSTF vice-chair Michael Barry, MD.
Are you seeing a rise in STI cases in your practice?
In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.
Listen
NIH study finds long-acting ART safe for HIV suppression in adolescents
March 7th 2024Research presented at the 2024 Conference on Retroviruses and Opportunistic Infections reveals that long-acting injectable antiretroviral therapy provides improved HIV suppression with minimal adverse effects, offering a promising alternative for adolescents and individuals struggling with daily oral regimens.
Read More
HIV remission among children reported over 1 year after treatment interruption
March 7th 2024Research presented at the 2024 Conference on Retroviruses and Opportunistic Infections reveals that 4 children, treated with antiretroviral therapy within 48 hours of birth, have achieved over a year of HIV remission.
Read More